Erythropoietin improves pulmonary hypertension by promoting the homing and differentiation of bone marrow mesenchymal stem cells in lung tissue
- 15 November 2023
- journal article
- research article
- Published by Springer Nature in Human Cell
- Vol. 37 (1) , 214-228
Abstract
Pulmonary arterial hypertension (PAH) is a chronic disease thatultimately progresses to right-sided heart failure and death. Erythropoietin (EPO) has been shown to have therapeutic potential in cardiovascular diseases, including PAH. In this study, we aimed to investigate the improvement effect of EPO pretreated bone marrow mesenchymal stem cells (BMSCs) on PAH. BMSCs were obtained from the bone marrow of male SD rats. Female rats were randomly divided into six groups, including control group, monocrotaline (MCT)-induced group, and four groups with different doses of EPO pretreated BMSCs. Lung tissue was taken for testing at 2 weeks of treatment. Our results showed EPO promoted homing and endothelial cell differentiation of BMSCs in the lung tissues of PAH rats. EPO and BMSCs treatment attenuated pulmonary arterial pressure, polycythemia, and pulmonary artery structural remodeling. Furthermore, BMSCs inhibited pulmonary vascular endothelial-to-mesenchymal transition (EndoMT) in PAH rats, which was further suppressed by EPO in a concentration-dependent manner. Meanwhile, EPO and BMSC treatment elevated pulmonary angiogenesis in PAH rats. BMSCs inhibited TNF-α, IL-1β, IL-6, and MCP-1 in lung tissues of PAH rats, which was further decreased by EPO in a concentration-dependent manner. Thus, EPO improved pulmonary hypertension (PH) by promoting the homing and differentiation of BMSCs in lung tissue.Keywords
Funding Information
- Key Project of Sichuan Science and Technology Agency (2020YFQ0042)
- National Natural Science Foundation of China (82174226)
This publication has 61 references indexed in Scilit:
- Effect of bone marrow mesenchymal stem cells on experimental pulmonary arterial hypertensionExperimental and Therapeutic Medicine, 2012
- Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia MicePLOS ONE, 2011
- Mesenchymal Stem CellsCell Transplantation, 2011
- Inflammation, immunological reaction and role of infection in pulmonary hypertensionClinical Microbiology and Infection, 2011
- Mesenchymal stem cells in health and diseaseNature Reviews Immunology, 2008
- Important Role of Endogenous Erythropoietin System in Recruitment of Endothelial Progenitor Cells in Hypoxia-Induced Pulmonary Hypertension in MiceCirculation, 2006
- Increased plasma monocyte chemoattractant protein‐1 level in idiopathic pulmonary arterial hypertensionRespirology, 2006
- AngiogenesisAnnual Review of Medicine, 2006
- Congenital erythropoietin over-expression causes “anti-pulmonary hypertensive” structural and functional changes in mice, both in normoxia and hypoxiaThrombosis and Haemostasis, 2005
- Administration of Recombinant Erythropoietin Determines Increase of Peripheral Resistances in Patients with Hypovolemic ShockNephron, 1996